Afshin Moradi on TSH Level and Stroke Severity
Afshin Moradi, Student and Researcher at Tabriz University of Medical Sciences, shared on LinkedIn:
”I’m pleased to share our recently published study exploring the relationship between thyroid-stimulating hormone (TSH) levels and stroke severity.
Key highlights:
• Stroke severity showed a significant inverse correlation with TSH levels during hospital admission and at discharge.
• Higher TSH levels were associated with less severe stroke symptoms in the acute phase.
• No significant association was found between TSH levels and stroke severity before admission or three months after discharge.
• TSH levels were not related to age, gender, stroke subtype, or CT findings.
These findings suggest a potential role of thyroid function in stroke severity, highlighting the need for further large-scale studies.”
Read the full article here.
Article: Association Between TSH Level and Stroke Severity: A Cross-Sectional Study Using the mRS
Authors: Afshin Moradi, Asal Ebrahimian, Seyed Ardalan Alhoseini, Kosar Baghernezhad, Amir Ghaffarzad, Sona Abolhasani, Vahideh Sadra, Samad Shams Vahdati

Stay updated on all scientific advances with Hemostasis Today.
-
Apr 10, 2026, 18:22Chris Hillis: Reflections on My Term as President of the Canadian Hematology Society
-
Apr 10, 2026, 17:59Michelle Leona Cecil: Representing Microhealth at The Coalition for Hemophilia B Annual Symposium
-
Apr 10, 2026, 17:47Lucie Raskin: Comparing VTE Risk in Hormonal Contraceptives at NTHC 2026
-
Apr 10, 2026, 17:39Diverse Voices But Shared Mission – Day 1 of EHC Youth Leadership Workshop
-
Apr 10, 2026, 17:30Make Your Mark at the World Stroke Congress 2026 – World Stroke Organization
-
Apr 10, 2026, 17:23Sofie Abels: Implications for Targeted Screening for Thrombophilia in Young Stroke Patients
-
Apr 10, 2026, 17:08Armghan Ans: 3 Questions Worth Sitting with If You Work in Stroke AI
-
Apr 10, 2026, 17:03William Wallace: Vitamin C Is More Than ”Immune Support”
-
Apr 10, 2026, 16:58Wolfgang Miesbach: Greater Symptom Burden in Women with Bleeding Disorders – Insights from Irish Data